Physician

Eduardo B. Fernandez, M.D.

According to 2025 Medicare claims, Eduardo Fernandez, M.D. (NPI: 1437209228) practices urology in the Laredo, TX market, with the plurality of this provider's patient population coming from Webb, TX. This provider's primary affiliated billing organization is REGIONAL EMPLOYEE ASSISTANCE PROGRAM INC (NPI: 1649232984; TIN: 621762428) and primary practice location at 78041-5456. Fernandez is affiliated with the CHSPSC ACO 17, LLC (ACO ID: A3694), CHSPSC ACO 14, LLC (ACO ID: A3724), and Caravan Health ACO 43 LLC (ACO ID: A4974), participating under the MSSP model.

Fernandez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 598 traditional Medicare patients, billed 2,502 HCPCS/CPT codes, and received $99,673 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 5,107 prescription claims across 1,124 beneficiaries totaling $551,159 in drug costs, led by Gemtesa (Vibegron). DME data shows 24 claims. Open Payments data shows 3 records totaling $65. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $200,602 to $99,673. In contrast, Part D prescription costs have risen steadily, from $324,619 to $551,159. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $1,113 to $184.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,362	5,237	$200,602
2016	1,315	5,780	$189,335
2017	1,188	5,209	$147,590
2018	1,053	4,456	$125,020
2019	938	4,312	$115,047
2020	687	2,825	$102,951
2021	691	3,366	$130,178
2022	626	2,417	$99,159
2023	606	2,882	$103,851
2024	598	2,502	$99,673

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	929	4,973	$324,619
2016	996	5,479	$375,604
2017	978	5,760	$390,863
2018	967	5,040	$422,329
2019	884	4,307	$348,554
2020	845	3,965	$405,770
2021	936	4,059	$413,060
2022	922	4,202	$447,921
2023	1,041	4,685	$492,149
2024	1,124	5,107	$551,159

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	109	$20,243
2016	N/R	104	$21,699
2017	N/R	107	$20,770
2018	N/R	53	$7,769
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	28	$7,188
2024	N/R	24	$7,291

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	46	47	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	41	42	$91
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	87	87	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	480	873	$60
81002	Urinalysis, manual test	478	880	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	294	14,473	$232,301
Myrbetriq	Mirabegron	298	13,597	$202,212
Fosfomycin Tromethamine	Fosfomycin Tromethamine	23	593	$11,118
Tamsulosin Hcl	Tamsulosin Hcl	1,129	76,355	$10,518
Solifenacin Succinate	Solifenacin Succinate	249	11,534	$10,082

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	12	$7,133
A4332	Lubricant, individual sterile packet, each	N	N/R	12	$159

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$65	Myriad Genetic Laboratories, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eduardo B. Fernandez, M.D.?

Tedicare shows public-source Medicare data for Eduardo B. Fernandez, M.D. (NPI 1437209228), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eduardo B. Fernandez, M.D. have ACO affiliation data?

Eduardo B. Fernandez, M.D. is shown with ACO affiliation data for CHSPSC ACO 17, LLC (MSSP, ACO ID A3694), CHSPSC ACO 14, LLC (MSSP, ACO ID A3724), and Caravan Health ACO 43 LLC (MSSP, ACO ID A4974).

What billing organization is linked to Eduardo B. Fernandez, M.D.?

Eduardo B. Fernandez, M.D. is linked to REGIONAL EMPLOYEE ASSISTANCE PROGRAM INC (billing NPI 1649232984) in the available physician profile data.

Does Eduardo B. Fernandez, M.D. have Open Payments data?

Eduardo B. Fernandez, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.